Rega marang bathi mangsa ngarep: Generation Bio Corp (GBIO)
How can mass access to non-viral gene delivery be ensured? The future P/E trajectory of Generation Bio Co. (GBIO) reflects a valuation trend where the 0.00 indicator determines the parameter status. The solution lies in a transparent partnership with Moderna and the scientific expertise of the management team. Business resilience is based on the ceDNA platform, which creates a robust technological barrier for long-term commercial success.
Rincian analitis lan laporan data perusahaan Generation Bio Corp (GBIO)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Total Utang marang Modal Generation Bio Co.|GBIO - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Generation Bio Co.|GBIO - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Generation Bio Co|GBIO - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Generation Bio|Rasio cepet generationbio.com
- statistik bathi lan rasio pasar:
GBIO - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep Generation Bio Co.|GBIO - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Generation Bio Co.|GBIO - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Generation Bio Co|GBIO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Generation Bio|GBIO - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan generationbio.com|GBIO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Generation Bio Co.
Analisis kabeh metrik perusahaan:GBIO Generation Bio
The asset valuation of Generation Bio Co. (GBIO) requires an analysis of the cost efficiency of outsourcing DNA platforms, which minimizes operational risks and impacts future profitability. The company's current forward P/E ratio relates the market value of the share to expected net income, allowing investors to determine the extent of capital overpayment or identify potential business undervaluation based on projected cash flows.
Karo sapa Generation Bio Co. saingan
Pangali Forward P/E TEM|QGEN - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Ionis Pharma IONS|Pangali mangsa ngarep rega marang bathi RGEN|Avidity Biosciences - Pangali Forward P/E|CRSP - Pangali Forward P/E|WGS (GeneDx) - Prakiraan rega marang bathi|RARE: Rasio kapitalisasi marang bathi mangsa ngarep|BEAM (Beam Therapeutics Corp) - Pangali Forward P/E|Sarepta Corp (SRPT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Twist Bioscience (TWST)|TXG - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Intellia Therapeutics, Inc. NTLA|STOK: Rasio rega marang bathi mangsa ngarep|BLFS: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi WVE (Wave Pharma)|MAZE: Pangali Forward P/E|SION (sionnatx.com) - Rega marang bathi mangsa ngarep|PRME (Prime Medicine) - Pangali Forward P/E|Taysha Gene Therapies Inc (TSHA) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep uniQure Corp (QURE)|MGTX - Rasio prakiraan rega marang bathi|REGENXBIO Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi SLDB|Ocugen - Pangali Forward P/E|Pacific Biosciences of California, Inc. (PACB) - Prakiraan rega marang bathi|Benitec (BNTC) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Design Corp (DSGN)|Prakiraan rega marang bathi RCKT|4dmoleculartherapeutics.com (FDMT) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E LXEO|korrobio.com (KRRO) - Pangali forward rega marang bathi|Pangali Forward P/E EDIT (Editas)|Silence Therapeutics Corp - Rega marang bathi mangsa ngarep|ProQR Therapeutics NV - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Codexis, Inc. CDXS|Sangamo Therapeutics, Inc. (SGMO) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Nautilus Bio (NAUT)|MGX (Metagenomi, Inc) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep DTIL (Precision BioSciences Inc.)|Rega marang bathi mangsa ngarep Boundless Bio, Inc. (BOLD)|exicuretx.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E IMNN (Imunon)|Pangali Forward P/E Phio Pharmaceuticals Corp PHIO|Mustang Bio Corp - Pangali Forward P/E|Pangali forward rega marang bathi TransCode Therapeutics (RNAZ)|BNGO: Pangali Forward P/E|Rasio prakiraan rega marang bathi adnas.com (APDN)|Rega marang bathi mangsa ngarep bluebird bio|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise)|Pangali Forward P/E OMGA|OMIC - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Regulus Therapeutics RGLS|Pangali mangsa ngarep rega marang bathi SYRS|Telesis Bio - Pangali Forward P/E|TCON - Pangali Forward P/E|UBX (Unity Bio) - Prakiraan rega marang bathi
